CAPRELSA
- Product NDC
- 58468-7860
- 11-digit product format
- 584687860
- Labeler code
- 58468
- Product ID
- 58468-7860_a8442300-a9bd-466b-ae0c-57531cf15820
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Vandetanib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Genzyme Corporation
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start
- 2022-06-24
- Marketing end
- 0000-00-00
- Substance
- VANDETANIB
- Active strength
- 300 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58468-7860-3 | 58468786003 | 3 BLISTER PACK in 1 CARTON (58468-7860-3) > 10 TABLET, FILM COATED in 1 BLISTER PACK | 3 blister pack | 2022-06-24 | 0000-00-00 | No | No | Current |